$JOE

ST JOE Co (JOE): Results of Operations and Financial Condition

ST JOE Co (JOE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ ​ THE ST. JOE COMPANY REPORTS SECOND QUARTER AND FIRST HALF 2026 RESULTS AND DECLARES A QUARTERLY DIVIDEND OF $0.16 PER SHARE ​ Highlights for the second quarter of 2026 as compared to the second quarter of 2025: ​ · Quarterly net income increased by 37% to $40.5 m

Original reporting
Published Jul 29, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 29, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$JOE
Bullish
medium confidence
Mentioned
$JOE
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$JOEBullishMed
01

Why it matters

Traders can update valuation assumptions around earnings power (net income and gross margin expansion), capital allocation (buybacks and dividend), and share count reduction, while monitoring residential pipeline conversion timing into future quarters.

02

Market read

A primary results release with multiple concrete operating and capital-return metrics, likely to influence near-term sentiment and earnings expectations.

03

What to watch

Unconsolidated joint venture revenue declined due to fewer home sales in the Latitude Margaritaville Watersound JV, which could offset consolidated momentum if JV activity remains soft.

Relevance 7/10Novelty 8/10Timing: after-hours filing of Q2 and first-half 2026 results on SEC 8-K

Background

The filing is an SEC Form 8-K (Item 2.02) with Exhibit 99.1 reporting second quarter and first half 2026 results and declaring a quarterly dividend.

Company-level read

Ticker impact

$JOEBullishMedium confidence
Context

ST JOE reported Q2 2026 revenue up 23% to $158.8M and net income up 37% to $40.5M, plus a $0.16/share dividend and $32.7M buyback.

Expected impact

Likely positive near-term bias, with follow-through dependent on whether the residential homesite pipeline and 2027 community commencements translate into sustained sales and margins.

Evidence & confidence

The filing is a primary earnings-style disclosure with multiple concrete datapoints (revenue, net income, segment revenue, gross margin by segment, buyback, dividend, and share count). However, the excerpt does not include guidance or balance-sheet detail, limiting conviction on forward estimates.

Market effects

Provides a read-through on Florida real estate and hospitality operating leverage, with segment gross margin expansion cited across residential, hospitality, and commercial.

Highlights demand and profitability in Panama City Beach and surrounding Florida land holdings, potentially reinforcing investor appetite for similar regional operators.

Limited global spillover; primarily a US regional real estate and hospitality earnings datapoint.

Counterpoint

Residential results are explicitly non-linear due to 1 to 2 year seeding and harvesting cycles, so near-term strength may not smoothly carry into subsequent quarters.

Key entities

  • The St. Joe Company

    Reported Q2 2026 revenue and net income growth, segment margin expansion, and announced a $0.16/share quarterly dividend alongside $32.7M of share repurchases.

Related articles

$OSCRHighAI 8/10

OSCR Looks 33.9% Overvalued on GF Value™ as Oscar Health Revises

Oscar Health (OSCR) revised its 2026 forecasts, raising operating earnings outlook by $100M to $600M-$800M and improving medical loss ratio guidance. Revenue guidance remains $18.7B-$19B. GF Value™ indicates OSCR is 33.9% overvalued at $32.44. The company has a strong GF Score™ of 83/100, with high growth and momentum ratings but middling profitability and valuation. Insiders have sold significantly more shares than they've bought.

$OSCRHighAI 8/10

Oscar Health boosts 2026 earnings outlook, affirms revenue

Oscar Health (OSCR) updated its 2026 earnings outlook, lowering its Medical Loss Ratio to 81.0%-82.0% and raising earnings from operations to $600M-$800M. The company reaffirmed revenue guidance of $18.7B-$19.0B and maintained SG&A expense ratio targets. The updates will be discussed at its 2026 Investor Day on September 16, 2026.

HighAI 8/10

Why is LuxExperience stock surging today?

LuxExperience BV DRC stock surged 15.9% in pre-market trading after reporting Q4 2026 net sales of €653.6M, beating estimates. The company also announced a $50M share buyback. Full-year sales rose 3.2% excluding currency effects, with three consecutive quarters of positive Adjusted EBITDA. Despite a Q4 EPS miss, investors focused on improving EBITDA and the buyback.

$UBERMedAI 8/10

Analyst calls robotaxi fears completely ridiculous

Analyst Daniel Badawi argues investors underestimate Uber's current growth, focusing too much on future robotaxi threats. Uber reported Q2 revenue of $14.2B, up 12% YoY, with delivery and freight revenue growing 28% and 26% respectively. Badawi expects 20%+ growth in the delivery segment and mobility recovery post-UK adjustments.

$JBHTHighAI 8/10

Why is JB Hunt Transport stock plunging today?

JB Hunt Transport (JBHT) shares dropped 8.8% pre-market after issuing an unusual intra-quarter earnings warning, forecasting a 5-10% profit decline from Q2 to Q3 2026. Barclays cut its price target to $285 from $300, citing near-term profitability concerns. The broader market showed little impact, indicating the selloff is company-specific.